Cargando…
Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
BACKGROUND: Several studies have found that Cathepsin B (CTSB) is up-regulated in many tumor types and facilitates tumor progression. However, the role of CTSB in hepatocellular carcinoma (HCC) progression remains unclear. This study was aimed at investigating the expression and role of CTSB in HCC...
Autores principales: | Ruan, Jian, Zheng, Haiyan, Rong, Xiaodong, Rong, Xiaomin, Zhang, Junyi, Fang, Weijia, Zhao, Peng, Luo, Rongcheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761221/ https://www.ncbi.nlm.nih.gov/pubmed/26896959 http://dx.doi.org/10.1186/s12943-016-0503-9 |
Ejemplares similares
-
Increased Expression of Cathepsin L: A Novel Independent Prognostic Marker of Worse Outcome in Hepatocellular Carcinoma Patients
por: Ruan, Jian, et al.
Publicado: (2014) -
The Association Between Body Mass Index and the Prognosis and Postoperative Complications of Hepatocellular Carcinoma: A Meta-Analysis
por: Rong, Xiaoxiang, et al.
Publicado: (2015) -
CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018) -
Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma
por: Guo, Xiaodong, et al.
Publicado: (2012) -
Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)